Journal
NEUROSCIENCE LETTERS
Volume 450, Issue 1, Pages 51-55Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.neulet.2008.11.023
Keywords
Alzheimer's disease; Tau; Hyperphosphorylation; Conformational change; Aggregation
Categories
Funding
- National Institute of Health [AG026478, AG022455]
Ask authors/readers for more resources
The clinical progression of Alzheimer's disease is closely related to tau pathology. Hyperphosphorylation of tau precedes histopathological evidence of tangle formation, and modulation of tau phosphorylation is a Promising therapeutic target. Although some phosphorylation sites are more critical in pathological processes, the importance of each phosphorylation site is unclear. In this study, we found that levels of phosphorylated tau drastically increased in crude and insoluble tau fractions with aging in a transgenic Mouse model of Alzheimer-type tauopathy. However, changes in the Soluble tau fraction were minor and phosphorylation at some sites was even reduced with aging. Total soluble (presumably functional) tau was reduced, while insoluble tau increased with aging. Synaptic proteins were reduced as insoluble tau increased. Taken together, these findings suggest that levels of soluble and insoluble tau are indicative of overall levels of tau phosphorylation, and may be useful markers to evaluate the effects of anti-tau therapeutic strategies in vivo. (c) 2008 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available